- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Elizabeth F. Lindquist (Liz)
News 3 results
In the News · Source: Washington Business Journal
December 8, 2021
Elizabeth Lindquist discusses the court ruling that has temporarily halted the Biden administration’s vaccination mandate for federal contractors
In the News · Source: Law360
In the News · Source: Law360
August 7, 2020
Elizabeth Lindquist comments on a new Trump executive order mandating that the government purchase critical drugs domestically
Events 8 results
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Speaking Engagement
October 11, 2021
Liz Lindquist to Speak at Informa Connect’s Medicaid Drug Rebate Program Conference
Webinar
September 9, 2021
14th Annual King & Spalding Medical Device Summit
Conference
November 12, 2019
12th Annual King & Spalding Pharmaceutical University
Insights 18 results
Client Alert
June 23, 2021
Pharmaceuticals and Active Pharmaceutical Ingredients - Biden Administration Issues 100-Day Supply Chain Review Report
COVID-19 Vaccine Updates
March 2, 2021
White House Invokes the Defense Production Act to Accelerate Johnson & Johnson Vaccine Production
COVID-19 Vaccine Updates
February 5, 2021
White House COVID-19 Response Team Discusses Use of DPA
Client Alert
December 31, 2020
Final Rule on VBP, Patient Assistance and Line Extensions Presents Opportunity and Risk for Drug Manufacturers